Geusens P, Oates M, Miyauchi A, et al. Romosozumab rapidly reduces clinical vertebral fracture incidence: results from the FRAME study. EULAR 2017, OP0048.
EULAR-aanbevelingen over CVRM bij reumatische en musculoskeletale aandoeningen
feb 2022 | Jicht, Sclerodermie, Sjögren, SLE